SHYAM VYAS: Open Payments
NPI 1992850184 · NACOGDOCHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 34 payments from 10 companies in 2025. Trend: 2023 $3,584 · 2024 $317 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 10 | $222 |
| Corium, LLC | 8 | $166 |
| ABBVIE INC. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Tris Pharma Inc | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: Jornay PM, Azstarys, VRAYLAR, Auvelity, CAPLYTA, Dyanavel XR, SPRAVATO, REXULTI.
Industry payments across TX — which companies pay providers there.
